Application of LC/MS and related techniques to high-throughput drug discovery

Drug Discovery Today

Volumn 13, Issue 9-10, 2008, Pages 417-423

  Espada, Alfonso ^a   Molina Martin, Manuel ^a   Dage, Jeffrey ^b   Kuo, Ming Shang ^b  

^a ELI LILLY AND COMPANY   (Spain)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; ANALYTIC METHOD; BIOLOGY; CHEMISTRY; CHIRALITY; DRUG DESIGN; DRUG PURIFICATION; DRUG PURITY; HIGH THROUGHPUT SCREENING; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; REVIEW; SEPARATION TECHNIQUE; STRUCTURE ACTIVITY RELATION; SUPERCRITICAL FLUID CHROMATOGRAPHY; TECHNOLOGY; TIME OF FLIGHT MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; DRUG DESIGN; MASS SPECTROMETRY;

EID: 43049161164     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.03.005     Document Type: Review

References (50)

1. Cuatrecasas P. Drug discovery in jeopardy. J. Clin. Invest. 116 (2006) 2837-2842
2. Russ A.P., and Lampel S. The druggable genome: an update. Drug Discov. Today 10 (2005) 1607-1610
3. Betz U.A.K. How many genomic targets can a portfolio afford?. Drug Discov. Today 10 (2005) 1057-1063
4. Korfmacher W.A. Principles and applications of LC-MS in new drug discovery. Drug Discov. Today 10 (2005) 1357-1367
5. Deng G., and Sanyal G. Applications of mass spectrometry in early stages of target based drug discovery. J. Pharm. Biomed. Anal. 40 (2006) 528-538
6. Prakash C., et al. Analytical strategies for identifying drug metabolites. Mass Spectrom. Rev. 26 (2007) 340-369
7. Fang A.S., et al. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery. Mass Spectrom. Rev. 27 (2008) 20-34
8. Chen G., et al. Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery. J. Mass Spectrom. 42 (2007) 279-287
9. Molina-Martín M., et al. Liquid chromatography-mass spectrometry and related techniques for purity assessment in early drug discovery. J. Sep. Sci. 28 (2005) 1742-1750
10. van de Merbel N.C., et al. Practical comparison of different approaches to speed up LC separations. LCGC Eur. 20 (2007) 32-40
11. Kyranos J.N., et al. One-minute full-gradient HPLC/UV/ELSD/MS analysis to support high-throughput parallel synthesis. J. Comb. Chem. 6 (2004) 796-804
12. Ceccato A., et al. A systematic approach for the development of liquid chromatographic methods. Org. Process Res. Dev. 11 (2007) 223-228
13. Anta C., et al. Does reversed-phase HPLC mimics olfactory chemoreception?. Abstracts of Papers, 29th International Symposium on High Performance Liquid Phase Separations and Related Techniques, June 26-30. Stockholm, Sweden (2005)
14. Marin A., et al. Optimization and standardization of liquid chromatography-mass spectrometry systems for the analysis of drug discovery compounds. J. Liq. Chromatogr. Relat. Tech. 31 (2008) 2-22
15. Sajonz P., et al. Multiparallel microfluidic high-performance liquid chromatography for high-throughput normal-phase chiral analysis. J. Chromatogr. A 1145 (2007) 149-154
16. st edn (2004), Blackwell 114-149
17. Schaffrath M., et al. High-throughput purification of single compounds and libraries. J. Comb. Chem. 7 (2005) 546-553
18. Isbell J.J., et al. Purifying the masses: integrating prepurification quality control, high-throughout LC/MS purification, and compound plating to feed high-throughput screening. J. Comb. Chem. 7 (2005) 210-217
19. Molina-Martin M., et al. Multifaceted role of monolithic columns in drug discovery: analytical and preparative applications in RP-HPLC. Abstracts of Papers, 31st International Symposium on High Performance Liquid Phase Separations and Related Techniques, June 17-21. Ghent, Belgium (2007)
20. Pinkston J.D., et al. Comparison of LC/MS and SFC/MS for screening of a large and diverse library of pharmaceutical relevant compounds. Anal. Chem. 78 (2006) 7467-7472
21. Poole S.K., et al. Determination of acid dissociation constants by capillary electrophoresis. J. Chromatogr. A 1037 (2004) 445-454
22. Miller J.M., et al. Semi-empirical relationships between effective mobility, charge, and molecular weight of pharmaceuticals by pressure-assisted capillary electrophoresis: applications in drug discovery. Electrophoresis 23 (2002) 2833-2841
23. a estimation using vacuum-assisted multiplexed capillary electrophoresis (VAMCE) with ultraviolet detection. J. Pharm. Sci. 94 (2005) 576-589
24. Wong K.S., et al. Validation and long-term assessment of an approach for the high throughput determination of lipophilicity (log P) values using multiplexed, absorbance-based capillary electrophoresis. J. Pharm. Sci. 93 (2004) 916-931
25. Wehmeyer K.R., et al. The application of multiplexed microemulsion electrokinetic chromatography for the rapid determination of log P values for neutral and basic compounds. LCGC N. Am. 21 (2003) 1078-1088
26. Di L., et al. Development and application of an automated solution stability assay for drug discovery. J. Biomol. Screen. 11 (2006) 40-47
27. Potter T., et al. Development of an automated stability assay on an Agilent 1200 LC-MS for use in drug discovery. Abstracts of Papers, 31st International Symposium on High Performance Liquid Phase Separations and Related Techniques, June 17-21. Ghent, Belgium (2007)
28. Quercia A.K., et al. High-throughput screening by mass spectrometry: comparison with the scintillation proximity assay with a focused-file screen of AKT1/PKBα. J. Biomol. Screen. 12 (2007) 473-480
29. Roddy T.P., et al. Mass spectrometric techniques for label-free high-throughput screening in drug discovery. Anal. Chem. 79 (2007) 8207-8213
30. Özbal C.C., et al. High-throughput screening via mass spectrometry: a case study using acethylcholinesterase. Assay Drug Dev. Technol. 2 (2004) 373-381
31. Sannes-Lowery K.A., et al. Fourier transform ion cyclotron resonance mass spectrometry as a high-throughput affinity screen to identify RNA binding ligands. Trends Anal. Chem. 19 (2000) 481-491
32. Jørgensen J.T. From blockbuster medicine to personalized medicine. Person. Med. 5 (2008) 55-63
33. Monetti M., et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 6 (2007) 69-78
34. Hu W., et al. Proteomics in cancer screening and management in gynecologic cancer. Curr. Onc. Rep. 6 (2004) 456-462
35. Drabik A., et al. Proteomics in neurosciences. Mass Spectrom. Rev. 26 (2007) 432-450
36. Chernet E., et al. Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 as examples. Life Sci. 78 (2005) 340-346
37. Zhang Z., et al. Applications of nanomaterials in liquid chromatography: opportunities for separation with high efficiency and selectivity. J. Sep. Sci. 29 (2006) 1872-1878
38. Welch C., et al. Comparison of multiparallel microfluidic HPLC instruments for high throughput analyses in support of pharmaceutical process research. J. Liq. Chrom. Relat. Tech. 29 (2006) 2185-2200
39. Trapp O. Boosting the throughput of separation techniques by multiplexing. Angew. Chem. Int. Ed. 46 (2007) 5609-5613
40. Livesay E.A., et al. Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses. Anal. Chem. 80 (2008) 294-302
41. Ishihama Y. Proteomic LC-MS systems using nanoscale liquid chromatography with tandem mass spectrometry. J. Chromatogr. A 1067 (2005) 73-83
42. Yin H., and Killen K. The fundamental aspects and applications of Agilent HPLC-Chip. J. Sep. Sci. 30 (2007) 1427-1434
43. van der Greef J., et al. The role of analytical sciences in medical systems biology. Curr. Opin. Chem. Biol. 8 (2004) 559-565
44. Liu B.-F., et al. Micro-separation toward systems biology. J. Chromatogr. A 1106 (2006) 19-28
45. Ackermann B.L., et al. The role of mass spectrometry in biomarker discovery and measurement. Curr. Drug Metab. 7 (2006) 525-539
46. Ackermann B.L., and Berna M.J. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers. Expert Rev. Proteomics 4 (2007) 175-186
47. Volmer D.A., and Sleno L. Modern drug discovery and the progression toward a universal mass spectrometer. Anal. Bioanal. Chem. 381 (2005) 90-92
48. Zhang S., et al. Quantitative determination of noncovalent binding interactions using automated nanoelectrospray mass spectrometry. Anal. Chem. 75 (2003) 3010-3018
49. Annis D.A., et al. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures. J. Am. Chem. Soc. 126 (2004) 15495-15503
50. Hsieh Y., and Korfmacher W.A. Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening. Curr. Drug Metab. 7 (2006) 479-489